Cytokinetics, Inc. (CYTK)
60.83
+0.77
(+1.28%)
USD |
NASDAQ |
Mar 16, 16:00
60.40
-0.43
(-0.71%)
After-Hours: 20:00
Cytokinetics Market Cap : 7.492B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 121.60B |
| Lifecore Biomedical, Inc. | 163.54M |
| Molina Healthcare, Inc. | 7.544B |
| Corcept Therapeutics, Inc. | 3.423B |
| Ionis Pharmaceuticals, Inc. | 11.95B |
Market Cap Related Metrics
| PS Ratio | 82.98 |
| PEG Ratio | -0.3912 |
| Price | 60.83 |
| Earnings Yield | -10.74% |
| PEGY Ratio | -0.3912 |